A detailed history of Engineers Gate Manager LP transactions in Viatris Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 170,767 shares of VTRS stock, worth $2.14 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
170,767
Holding current value
$2.14 Million
% of portfolio
0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $1.76 Million - $2.07 Million
170,767 New
170,767 $1.98 Million
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $1.37 Million - $1.64 Million
121,168 New
121,168 $1.45 Million
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $403,572 - $460,395
-44,742 Reduced 62.37%
27,000 $269,000
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $1.5 Million - $2 Million
-163,146 Reduced 69.46%
71,742 $690,000
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $1.57 Million - $2.08 Million
180,146 Added 329.08%
234,888 $2.61 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $464,212 - $609,278
54,742 New
54,742 $466,000
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $759,702 - $936,839
-76,352 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $2.44 Million - $3.83 Million
-248,515 Reduced 76.5%
76,352 $831,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $150,979 - $183,323
-12,488 Reduced 3.7%
324,867 $4.4 Million
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $4.47 Million - $5.1 Million
337,355 New
337,355 $4.57 Million
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $3.11 Million - $3.87 Million
-239,850 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$13.59 - $18.54 $2.79 Million - $3.81 Million
205,559 Added 599.45%
239,850 $3.35 Million
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $490,361 - $642,613
34,291 New
34,291 $643,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.